×
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

Lupin Tarapur facility gets 3 observations from USFDA

Last Updated 23 September 2019, 08:47 IST

Pharma major Lupin on Monday said the US health regulator has issued three observations after inspection of its Tarapur facility in Maharashtra.

The inspection of Tarapur facility was carried out by the United States Food and Drug administration (USFDA) between September 16-20, 2019.

"The inspection at the Tarapur facility closed with three observations," Lupin said in a regulatory filing.

Lupin did not elaborate on the nature of the observations.

"The Company is confident of addressing them satisfactorily," the filing added.

Shares of Lupin were trading 3.52 per cent lower at Rs 729.50 apiece on BSE.

ADVERTISEMENT
(Published 23 September 2019, 08:40 IST)

Follow us on

ADVERTISEMENT
ADVERTISEMENT